-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2014 to Q2 2024.
- KalVista Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending July 31, 2024 was $224K, a 16.1% increase year-over-year.
- KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $816K, a 13.6% increase from 2022.
- KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $718K, a 27.3% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $564K, a 5.03% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)